Company intelligence / Profile preview

Entheon Biomedical

Vancouver, British Columbia, Canadaentheonbiomedical.com ↗

Ownership: Private
Development stage: Other

Overview

Entheon Biomedical has initiated clinical studies to evaluate the safety and efficacy of DMT for addiction treatment. As of March 2022, they announced enrollment in a Phase 1 study. The company has also launched multiple studies to advance psychedelic-based mental health treatments[2].

Therapeutic areas: Psychiatry
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Entheon Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Entheon Biomedical.

Explore the full profile